Bronchiectasis: Clinical Trials

8 trials for Bronchiectasis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 unknown. 8 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 48Unknown 8

Follow Bronchiectasis: new trials by email Literature Review of Bronchiectasis trials Research Report on Bronchiectasis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis
Ceftolozane/tazobactam - Bronchiectasis, Cystic Fibrosis
Phase 4UnknownSunshine Coast Hospital and Health Service302023-10-012023-09-13
A Series of N-of-1 Trials of Traditional Chinese Medicine Based on Bayesian Method
Individualized Decoction, placebo, Tested drug minus heat-clearing herbs - Bronchiectasis, Quality of Life
Phase 4UnknownShanghai University of Traditional Chinese Medicine712019-12-012020-10-26
Comparisons of Inhaled LAMA or LAMA+LABA or ICS+LABA for COPD With Bronchiectasis
Symbicort, Spiriva - COPD, Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China902017-09-152019-08-01
Evaluating the Effects of Traditional Chinese Medicine by N-of-1 Trials
Individualized Decoction, placebo, Tested drug minus heat-clearing herbs - Bronchiectasis, Quality of Life
Phase 4UnknownShanghai University of Traditional Chinese Medicine362017-03-012017-05-10
Vitamin D as an Adjunctive Treatment in Patients With Non-Cystic Fibrosis Bronchiectasis
Cholecalciferol, Placebo - Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China2002015-01-012015-07-24
Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis
Bronchoalveolar Lavage and Local Amikacin Injection - Bronchiectasis
Phase 4UnknownShanghai Pulmonary Hospital, Shanghai, China1002014-12-012018-08-22
Use of Roflumilast to Prevent Exacerbations in Fibrotic Sarcoidosis Patients (REFS)
Roflumilast, Placebo - Sarcoidosis
Phase 4UnknownUniversity of Cincinnati502013-04-012015-12-08
A Study to Access Safety and Efficacy of Nebulized Tobramycin in Patients With Bronchiectasis
Tobramycin, Saline - Bronchiectasis
Phase 4UnknownShandong University1202012-08-012012-12-05

Narrower conditions

Burkholderia Infections (1)  ·  Cystic Fibrosis (1)  ·  Fibrosis (1)  ·  Pseudomonas Infections (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Sarcoidosis (1)

Broader conditions

Bronchial Diseases (8)  ·  Respiratory Tract Diseases (8)  ·  Lung Diseases (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Bacterial Infections (1)  ·  Bacterial Infections and Mycoses (1)  ·  Chronic Disease (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Digestive System Diseases (1)  ·  Disease Attributes (1)  ·  Genetic Diseases, Inborn (1)  ·  Gram-Negative Bacterial Infections (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Hypersensitivity (1)

Interventions

Bronchoalveolar Lavage (1)  ·  Budesonide, Formoterol Fumarate Drug Combination (1)  ·  Cholecalciferol (1)  ·  Roflumilast (1)  ·  Sodium Chloride (1)  ·  Tiotropium Bromide (1)  ·  Tobramycin (1)  ·  ceftolozane, tazobactam drug combination (1)

Sponsors

Shanghai Pulmonary Hospital, Shanghai, China (3)  ·  Shanghai University of Traditional Chinese Medicine (2)  ·  Shandong University (1)  ·  Sunshine Coast Hospital and Health Service (1)  ·  University of Cincinnati (1)

Countries

China (6)  ·  United States (1)

Top investigators

Andrew Burke, MBBS (1)  ·  Jin-Fu Xu (1)  ·  Jin-Fu Xu, MD (1)  ·  JinFu Xu (1)  ·  Julia J Bashford, BSc, MBBS (1)  ·  Robert P Baughman, MD (1)

Results publications

PMID 21398686, PMID 21697993, PMID 23076388, PMID 23101012, PMID 23371406, PMID 24232697, PMID 24671923, PMID 24872685, PMID 24952426, PMID 25477988, PMID 29552084, PMID 34122611, PMID 34744427, PMID 35087595